The reignited Cancer Moonshot must support science that will tackle health and economic impacts of cancer and promote health equity in low- and middle-income countries.
This is a preview of subscription content, access via your institution
Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$29.99 / 30 days
cancel any time
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Sleeman, K. E. et al. Lancet Glob. Health 7, e883–e892 (2019).
Guida, F. et al. Nat. Med. 28, 2563–2572 (2022).
Chen, S. et al. JAMA Oncol. https://doi.org/10.1001/jamaoncol.2022.7826 (2023).
Acknowledgements
The opinions expressed in this article are the author’s own and do not reflect the view of the US National Institutes of Health, the US Department of Health and Human Services or the US Government.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The author declares no competing interests.
Rights and permissions
About this article
Cite this article
Gopal, S. Tackling cancer globally requires research commitments in LMICs. Nat Med 29, 2395 (2023). https://doi.org/10.1038/s41591-023-02472-8
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41591-023-02472-8